Intellectual Property

NeoImmuneTech obtained the right on development and commercialization of Hyleukin as well as other undisclosed hyFc-based products from Genexine, Inc. ( for the territory including North America, South America, and Europe.

Title Country Patent Application No. Original Assignee Filing Date
Immunoglobulin Fusion Proteins US 7867491 Genexine, Inc. /POSTECH 2010.12.28
Chimeric Immunoglobulin Fusion Proteins US 8586038 Genexine, Inc. 2013.11.19
Immunoglobulin Fusion Proteins EP 2162472 Genexine, Inc. /POSTECH 2010.03.17
Immunoglobulin Fusion Proteins CA 2687377 Genexine, Inc. /POSTECH 2013.05.14
Novel Immunotherapy KR 2015-0043564 Genexine, Inc. /BioDion Co.,Ltd 2015
Modified interleukin-7 protein and uses thereof KR 2015-0082793 Genexine, Inc. 2015
To install the latest Internet Explorer